Paper Details
- Home
- Paper Details
[Clinical studies of cefoxitin for the treatment of respiratory tract infections (author's transl)].
Author: FujiiK, HattoriJ, IshikawaH, ItoT, IwakuraM, IzumiS, KatayamaT, KatohT, KobayashiT, MaedaF, MoriseM, NaitoT, NishimuraM, NishiwakiK, NomuraY, SakaiS, ShimokataK, SuetsuguS, SuzukiK, TakeuraS, TsunekawaH, UmedaH, YoshiiS, YoshikawaK
Original Abstract of the Article :
A total of 42 patients who were suffering from respiratory tract infections were treated with cefoxitin, and the following results were obtained. 1. Out of 32 patients clinically evaluated, excellent or good responses were observed in 30 patients (94%). 2. Presumed causative organisms were isolated ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://pubmed.ncbi.nlm.nih.gov/7087175
データ提供:米国国立医学図書館(NLM)
Cefoxitin: A Promising Antibiotic for Respiratory Infections
The field of infectious diseases is always in pursuit of effective and safe antibiotics to combat the ever-evolving microbial world. This study delves into the therapeutic potential of cefoxitin in treating respiratory tract infections. Employing a clinical trial, researchers assessed the efficacy and safety of cefoxitin in a cohort of 42 patients. The findings revealed that cefoxitin demonstrated a significant clinical response in 94% of the patients, with notable eradication of causative organisms in a substantial portion of the group. The researchers also observed that cefoxitin exhibited a favorable safety profile, with only minor side effects reported.
Cefoxitin's Effectiveness in Treating Respiratory Infections
The results of this study suggest that cefoxitin is a valuable weapon in the fight against respiratory tract infections. The high efficacy rates observed in the trial, particularly the 94% success rate in clinical evaluations, are encouraging. The researchers' emphasis on the eradication of presumed causative organisms further strengthens the case for cefoxitin's effectiveness. It's like finding a hidden oasis in the middle of a vast desert! This research indicates that cefoxitin could be a viable option for treating respiratory infections.
The Safety and Applicability of Cefoxitin
The study emphasizes the importance of considering the potential side effects of any medication. While cefoxitin appears to have a relatively favorable safety profile, the researchers noted some instances of skin eruption and slight elevations in liver enzymes. However, these side effects were generally mild and resolved after treatment completion. It's important to remember that, like a desert landscape, every individual is different. What works for one person might not work for another. This underscores the need for personalized medicine and careful monitoring when administering cefoxitin.
Dr. Camel's Conclusion
This study sheds light on the potential of cefoxitin as a safe and effective antibiotic for the treatment of respiratory tract infections. While further research is always necessary, the findings offer a glimmer of hope in the ongoing battle against infectious diseases. It's like discovering a new source of water in the arid desert, providing a much-needed resource for those in need.
Date :
- Date Completed 1982-08-14
- Date Revised 2016-11-16
Related Literature
Japanese
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.